Faricimab Quarterly Maintenance for Neovascular Age Related Macular Degeneration

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Faricimab Quarterly Maintenance for Neovascular Age Related Macular Degeneration	Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, choroidal neovascularization, eye disorder, optic choroid disorder, uveal disorder	Recruiting	Phase 4	2025-10-01		NCT06742307

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hospital Authority, Hong Kong	12

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Department of Ophthalmology, United Chrisitian Hospital	Hong Kong	Hong Kong	1

Clinical trials